Literature DB >> 18298568

Assessment of erectile dysfunction in diabetic patients.

Farqad B Hamdan1, Hisham Y Al-Matubsi.   

Abstract

Erectile dysfunction (ED) aetiology is multifactorial, including endocrine, neurological, vascular, systemic disease, local penile disorders, nutrition, psychogenic factors, and drug-related. This study was performed to compare the relevant comprehensive biochemical parameters as well as the clinical characteristics in diabetic ED and healthy control subjects and to assess the occurrence of penile neuropathy in diabetic patients and thus the relationship between ED and diabetes. A total of 56 patients accepted to undergo assessment for penile vasculature using intracavernosal injection and colour Doppler ultrasonography. Of the 56 diabetic patients, 38 patients were found with normal blood flow and thus they were considered as the diabetic-ED group, whereas, ED diabetic patients with an arteriogenic component were excluded. These patients with an age range between 17 and 58 years, complaining of ED, with duration of diabetic illness ranging from 2 to 15 years. The Control group comprised of 30 healthy subject aged between 19 and 55 years. Peripheral venous levels of testosterone, prolactin, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), malondialdehyde and glycosylated haemoglobin (HbA(1)c) were obtained in all subjects. Valsalva manoeuvre and neurophysiological tests were also determined. Testosterone, prolactine, FSH, LH, and TSH hormones of the diabetic patients were not significantly different from those of the control group. Diabetic patients with ED have higher HbA(1)c and oxidative stress levels while the R-R ratio was significantly decreased. Bulbocavernosus reflex latency was significantly prolonged, whereas its amplitude, the conduction velocity and amplitude of dorsal nerve of penis were significantly reduced in the diabetic patients. We concluded that although ED is a multifactorial disorder, yet, the present study revealed that in ED patients without arteriogenic ED a neurogenic component is present. Furthermore, the complex effect of the Valsalva manoeuvre on cardiovascular function is the basis of its usefulness as a measure of autonomic function. Thus, it can be of value in the diagnosis of ED although these hypotheses require follow-up in a large study cohort.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18298568     DOI: 10.1111/j.1365-2605.2008.00873.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  8 in total

1.  Constitutive NOS uncoupling and NADPH oxidase upregulation in the penis of type 2 diabetic men with erectile dysfunction.

Authors:  B Musicki; A L Burnett
Journal:  Andrology       Date:  2017-01-11       Impact factor: 3.842

2.  Sexual dysfunctions in patients with diabetes: a study from Iran.

Authors:  Marzieh Ziaei-Rad; Mariam Vahdaninia; Ali Montazeri
Journal:  Reprod Biol Endocrinol       Date:  2010-05-18       Impact factor: 5.211

Review 3.  Urogenital Autonomic Dysfunction in Diabetes.

Authors:  Barbara H Braffett; Hunter Wessells; Aruna V Sarma
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 5.430

Review 4.  Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.

Authors:  Solomon Tesfaye; Andrew J M Boulton; Peter J Dyck; Roy Freeman; Michael Horowitz; Peter Kempler; Giuseppe Lauria; Rayaz A Malik; Vincenza Spallone; Aaron Vinik; Luciano Bernardi; Paul Valensi
Journal:  Diabetes Care       Date:  2010-10       Impact factor: 19.112

5.  A study to evaluate the prevalence of hypogonadism in Indian males with Type-2 diabetes mellitus.

Authors:  Pankaj Kumar Agarwal; Parminder Singh; Subhankar Chowdhury; S K Sharma; Anirban Majumdar; Parag Shah; Rakesh Sahay; S Vageesh Ayyar; Hemant Phatale; Chandar M Batra; Raeesuddin Syed; Pradeep Shetty
Journal:  Indian J Endocrinol Metab       Date:  2017 Jan-Feb

6.  Traditional Chinese medicine on treating diabetic mellitus erectile dysfunction: Protocol for a systematic review and meta-analysis.

Authors:  Xudong D Yu; Jisheng S Wang; Guang Zuo; Xin Wang; Fuxing Ge; Songli Wu; Jingyang Lim; Jianwei Shang; Yaosheng Zhang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

Review 7.  Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Xiang Cai; Ye Tian; Tao Wu; Chen-Xi Cao; Hong Li; Kun-Jie Wang
Journal:  Asian J Androl       Date:  2014 Jan-Feb       Impact factor: 3.285

8.  The safety and efficacy of PDE5-inhibitors-vardenafil on treating diabetes mellitus erectile dysfunction: A protocol for systematic review and meta analysis.

Authors:  Jia He; Xiao Li; Heng-Heng Dai; Ji-Sheng Wang; Hai-Song Li; Xiao-Jun Zhang; Ping Wang; Dong Zhang; Ling-Yan Zuo; Ning Xie; Ying Li
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.